UTHR position history
The shares of United Therapeutics (UTHR) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 687,206 shares, $127M, 7.7% of portfolio
- 2021 Q4: 687,206 shares, $148M, 9.5% of portfolio
- 2022 Q1: 653,079 shares, $117M, 9.1% of portfolio, Reduce −5.0%
- 2022 Q2: 634,806 shares, $150M, 13.0% of portfolio, Reduce −2.8%
- 2022 Q3: 633,534 shares, $133M, 10.5% of portfolio, Reduce −0.2%
- 2022 Q4: 625,414 shares, $174M, 14.8% of portfolio, Reduce −1.3%
- 2023 Q1: 627,514 shares, $141M, 11.6% of portfolio, Add +0.3%
- 2023 Q2: 627,514 shares, $139M, 11.2% of portfolio
- 2023 Q3: 575,907 shares, $130M, 12.3% of portfolio, Reduce −8.2%
- 2023 Q4: 791,568 shares, $174M, 15.7% of portfolio, Add +37.4%
- 2024 Q1: 267,759 shares, $62M, 6.9% of portfolio, Reduce −66.2%
- 2024 Q2: 266,914 shares, $85M, 9.9% of portfolio, Reduce −0.3%
- 2024 Q3: 183,246 shares, $66M, 8.5% of portfolio, Reduce −31.3%
- 2024 Q4: 155,714 shares, $55M, 8.5% of portfolio, Reduce −15.0%
- 2025 Q1: 105,228 shares, $32M, 6.2% of portfolio, Reduce −32.4%
- 2025 Q2: 95,482 shares, $27M, 5.8% of portfolio, Reduce −9.3%
- 2025 Q3: 58,186 shares, $24M, 4.5% of portfolio, Reduce −39.1%
- 2025 Q4: 58,186 shares, $28M, 3.9% of portfolio
- 2026 Q1: 62,809 shares, $37M, 5.7% of portfolio, Add +7.9%
- 2026 Q2: 62,587 shares, $34M, 4.7% of portfolio, Reduce −0.4%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|